X-Chem, Vertex drug discovery deal
X-Chem Inc. (Waltham, Mass.) will use its X-Chem's DEX library to discover small molecules against undisclosed targets implicated in severe genetic diseases. Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has exclusive options to license and develop compounds discovered under the deal, which may be expanded to include additional targets...